Price (delayed)
$185.78
Market cap
$33.5B
P/E Ratio
68.3
Dividend/share
N/A
EPS
$2.72
Enterprise value
$32.64B
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington , is
There are no recent dividends present for SGEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.